logo-loader
viewAdmedus Ltd

Admedus using capital raised to advance product development and share price growth

Admedus Ltd (ASX:AHZ) chief executive Wayne Paterson updates Proactive Investors on product development, a major agreement, key executive appointments, and strategic financing decisions.

The global medical technologies company recently completed a $6 million capital raise. "On what is our strategy to move that share price; I realised that if we developed the portfolio, the share price would move much more quickly, and would certainly flush out any dilution impact of a small cap raise... I think [we're] probably going to bring forward the progress of the company by a couple of years," says Paterson.

Admedus has recently appointed key staff members with big pharma backgrounds. Paterson comments, "we've got very good assets, we've got a clear sense of strategy, we're growing the business dramatically, and we are now getting those folks; both in the field force [and in] key positions."

The drug development Immunotherapies Division has attracted a financing partner which will hold a majority stake moving forwards. Paterson explains that shareholders will "get to participate in the upside without putting any more money into that project, so it's a very good outcome."  

Meanwhile, development of the company’s flagship portfolio of 3D moulded surgical solutions continues. "If you imagine Admedus three years from now it will be the only company in the world, as far as I'm aware, that can make 3D surgical collagen solutions," says Paterson.

Quick facts: Admedus Ltd

Price: 0.09 AUD

ASX:AHZ
Market: ASX
Market Cap: $53.18 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Admedus Ltd named herein, including the promotion by the Company of Admedus Ltd in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Admedus Ltd proud to unveil its valves publicly for the first time in London

Admedus Ltd's (ASX:AHZ) CEO Wayne Paterson caught up with Proactive's Andrew Scott while in London. The firm recently made what's been described as a transformational move to sell off its CardioCel® and VascuCel® patch business. Paterson says the focus is now firmly on the Adapt...

2 weeks, 4 days ago

2 min read